(AEF) Abrdn Emerging Markets - Ratings and Ratios
Exchange: NYSE MKT • Country: United Kingdom • Currency: USD • Type: Fund • ISIN: US00301W1053
AEF: Stocks, Bonds, Equities, Fixed Income, Securities
Abrdn Emerging Markets Equity Income Fund Inc is a closed ended balanced mutual fund and managed by Aberdeen Asset Managers Limited. It invests in the public equity and fixed income markets of Chile. The fund seeks to invest in securities of companies operating across diversified sectors. It employs fundamental analysis with a bottom-up security selection approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI Chile Index. It conducts in-house research to create its portfolio. The fund was formerly known as Aberdeen Chile Fund, Inc. Abrdn Emerging Markets Equity Income Fund Inc was formed on January 30, 1989 and is domiciled in the United States., Web URL: https://www.aberdeench.com
Additional Sources for AEF Fund
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AEF Fund Overview
| Market Cap in USD | 280m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2001-01-02 |
AEF Fund Ratings
| Growth 5y | 14.9% |
| Fundamental | 32.7% |
| Dividend | 62.1% |
| Rel. Strength Industry | -9.94 |
| Analysts | - |
| Fair Price Momentum | 5.11 USD |
| Fair Price DCF | 0.93 USD |
AEF Dividends
| Dividend Yield 12m | 7.35% |
| Yield on Cost 5y | 7.51% |
| Annual Growth 5y | 7.24% |
| Payout Consistency | 64.1% |
AEF Growth Ratios
| Growth Correlation 3m | 74.3% |
| Growth Correlation 12m | 83.4% |
| Growth Correlation 5y | -13.2% |
| CAGR 5y | 1.18% |
| CAGR/Max DD 5y | 0.03 |
| Sharpe Ratio 12m | 0.67 |
| Alpha | -1.25 |
| Beta | 0.81 |
| Volatility | 16.48% |
| Current Volume | 151.2k |
| Average Volume 20d | 312.1k |
What is the price of AEF stocks?
As of February 23, 2025, the stock is trading at USD 5.50 with a total of 151,248 shares traded.
Over the past week, the price has changed by -0.36%, over one month by +3.97%, over three months by +8.00% and over the past year by +17.11%.
As of February 23, 2025, the stock is trading at USD 5.50 with a total of 151,248 shares traded.
Over the past week, the price has changed by -0.36%, over one month by +3.97%, over three months by +8.00% and over the past year by +17.11%.
Is Abrdn Emerging Markets a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Abrdn Emerging Markets is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AEF as of February 2025 is 5.11. This means that AEF is currently overvalued and has a potential downside of -7.09%.
Neither. Based on ValueRay Fundamental Analyses, Abrdn Emerging Markets is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AEF as of February 2025 is 5.11. This means that AEF is currently overvalued and has a potential downside of -7.09%.
Is AEF a buy, sell or hold?
Abrdn Emerging Markets has no consensus analysts rating.
Abrdn Emerging Markets has no consensus analysts rating.
What are the forecast for AEF stock price target?
According to ValueRays Forecast Model, AEF Abrdn Emerging Markets will be worth about 6.1 in February 2026. The stock is currently trading at 5.50. This means that the stock has a potential upside of +10.18%.
According to ValueRays Forecast Model, AEF Abrdn Emerging Markets will be worth about 6.1 in February 2026. The stock is currently trading at 5.50. This means that the stock has a potential upside of +10.18%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.1 | 10.2% |